Lara M. Mangravite, Ph.D. - Publications

Affiliations: 
2002 University of California, San Francisco, San Francisco, CA 
Area:
Pharmaceutical Chemistry, Pharmacology, Cell Biology

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Allen M, Carrasquillo MM, Funk C, Heavner BD, Zou F, Younkin CS, Burgess JD, Chai HS, Crook J, Eddy JA, Li H, Logsdon B, Peters MA, Dang KK, Wang X, ... ... Mangravite LM, et al. Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseases. Scientific Data. 3: 160089. PMID 27727239 DOI: 10.1038/Sdata.2016.89  0.305
2014 Yu CY, Theusch E, Lo K, Mangravite LM, Naidoo D, Kutilova M, Medina MW. HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism. Human Molecular Genetics. 23: 319-32. PMID 24001602 DOI: 10.1093/Hmg/Ddt422  0.301
2013 Mangravite LM, Engelhardt BE, Medina MW, Smith JD, Brown CD, Chasman DI, Mecham BH, Howie B, Shim H, Naidoo D, Feng Q, Rieder MJ, Chen YD, Rotter JI, Ridker PM, et al. A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. Nature. 502: 377-80. PMID 23995691 DOI: 10.1038/Nature12508  0.321
2013 Brown CD, Mangravite LM, Engelhardt BE. Integrative Modeling of eQTLs and Cis-Regulatory Elements Suggests Mechanisms Underlying Cell Type Specificity of eQTLs Plos Genetics. 9. PMID 23935528 DOI: 10.1371/Journal.Pgen.1003649  0.301
2010 Oshiro C, Mangravite L, Klein T, Altman R. PharmGKB very important pharmacogene: SLCO1B1. Pharmacogenetics and Genomics. 20: 211-6. PMID 19952871 DOI: 10.1097/Fpc.0B013E328333B99C  0.458
2009 Welsh M, Mangravite L, Medina MW, Tantisira K, Zhang W, Huang RS, McLeod H, Dolan ME. Pharmacogenomic discovery using cell-based models. Pharmacological Reviews. 61: 413-29. PMID 20038569 DOI: 10.1124/Pr.109.001461  0.313
2006 Erdman AR, Mangravite LM, Urban TJ, Lagpacan LL, Castro RA, de la Cruz M, Chan W, Huang CC, Johns SJ, Kawamoto M, Stryke D, Taylor TR, Carlson EJ, Ferrin TE, Brett CM, et al. The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics. American Journal of Physiology. Renal Physiology. 290: F905-12. PMID 16291576 DOI: 10.1152/Ajprenal.00272.2005  0.712
2004 Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D, Kawamoto M, Johns SJ, DeYoung J, Carlson E, Ferrin TE, Herskowitz I, Giacomini KM. PharmGKB update: III. Genetic variants of SLC22A1, solute carrier family 22 (organic cation transporter), member 1. Pharmacological Reviews. 56: 161. PMID 15169925 DOI: 10.1124/Pr.56.2.2  0.728
2004 Gray JH, Mangravite LM, Owen RP, Urban TJ, Chan W, Carlson EJ, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, Giacomini KM. Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations. Molecular Pharmacology. 65: 512-9. PMID 14978229 DOI: 10.1124/Mol.65.3.512  0.729
2004 Mangravite LM, Badagnani I, Giacomini KM. Corrigendum to “Nucleoside transporters in the disposition and targeting of nucleoside 2 analogs in the kidney” [Eur. J. Pharmacol. 479/1–3 (2003) 269–281] European Journal of Pharmacology. 486: 239. DOI: 10.1016/J.Ejphar.2003.12.019  0.718
2004 Mangravite L. Identification and functional characterization of variants of the human organic anion transporter, OAT3 (SLC22A8) Clinical Pharmacology & Therapeutics. 75: P93. DOI: 10.1016/J.Clpt.2003.11.356  0.451
2003 Mangravite LM, Badagnani I, Giacomini KM. Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney. European Journal of Pharmacology. 479: 269-81. PMID 14612157 DOI: 10.1016/J.Ejphar.2003.08.076  0.737
2003 Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D, Kawamoto M, Johns SJ, DeYoung J, Carlson E, Ferrin TE, Herskowitz I, Giacomini KM. Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proceedings of the National Academy of Sciences of the United States of America. 100: 5902-7. PMID 12719534 DOI: 10.1073/Pnas.0730858100  0.728
2003 Mangravite LM, Giacomini KM. Sorting of rat SPNT in renal epithelium is independent of N-glycosylation. Pharmaceutical Research. 20: 319-23. PMID 12636174 DOI: 10.1023/A:1022247826750  0.564
2003 Mangravite LM, Xiao G, Giacomini KM. Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells. American Journal of Physiology. Renal Physiology. 284: F902-10. PMID 12527552 DOI: 10.1152/Ajprenal.00215.2002  0.605
2001 Cummins CL, Mangravite LM, Benet LZ. Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Pharmaceutical Research. 18: 1102-9. PMID 11587480 DOI: 10.1023/A:1010914624111  0.348
2001 Shu Y, Bello CL, Mangravite LM, Feng B, Giacomini KM. Functional characteristics and steroid hormone-mediated regulation of an organic cation transporter in Madin-Darby canine kidney cells. The Journal of Pharmacology and Experimental Therapeutics. 299: 392-8. PMID 11561104  0.521
2001 Mangravite LM, Lipschutz JH, Mostov KE, Giacomini KM. Localization of GFP-tagged concentrative nucleoside transporters in a renal polarized epithelial cell line. American Journal of Physiology. Renal Physiology. 280: F879-85. PMID 11292631 DOI: 10.1152/Ajprenal.2001.280.5.F879  0.594
Show low-probability matches.